Style | Citing Format |
---|---|
MLA | Mirshahvalad SA, et al.. "Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis." Nuclear Medicine Communications, vol. 43, no. 8, 2022, pp. 860-868. |
APA | Mirshahvalad SA, Chavoshi M, Bahmani Kashkouli M, Fallahi B, Emamiardakani A, Manafifarid R (2022). Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis. Nuclear Medicine Communications, 43(8), 860-868. |
Chicago | Mirshahvalad SA, Chavoshi M, Bahmani Kashkouli M, Fallahi B, Emamiardakani A, Manafifarid R. "Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis." Nuclear Medicine Communications 43, no. 8 (2022): 860-868. |
Harvard | Mirshahvalad SA et al. (2022) 'Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis', Nuclear Medicine Communications, 43(8), pp. 860-868. |
Vancouver | Mirshahvalad SA, Chavoshi M, Bahmani Kashkouli M, Fallahi B, Emamiardakani A, Manafifarid R. Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis. Nuclear Medicine Communications. 2022;43(8):860-868. |
BibTex | @article{ author = {Mirshahvalad SA and Chavoshi M and Bahmani Kashkouli M and Fallahi B and Emamiardakani A and Manafifarid R}, title = {Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis}, journal = {Nuclear Medicine Communications}, volume = {43}, number = {8}, pages = {860-868}, year = {2022} } |
RIS | TY - JOUR AU - Mirshahvalad SA AU - Chavoshi M AU - Bahmani Kashkouli M AU - Fallahi B AU - Emamiardakani A AU - Manafifarid R TI - Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis JO - Nuclear Medicine Communications VL - 43 IS - 8 SP - 860 EP - 868 PY - 2022 ER - |